Related Experiment Videos
A simple chromogenic assay for arylsulfatase A
Summary
A new assay accurately measures low arylsulfatase A (ARSA) activity in MLD patients. This method differentiates between MLD patients and pseudodeficiency, aiding diagnosis.
Area of Science:
- Biochemistry
- Enzymology
- Clinical Diagnostics
Background:
- Arylsulfatase A (ARSA) deficiency causes Metachromatic Leukodystrophy (MLD).
- Accurate measurement of residual ARSA activity is crucial for diagnosing MLD and pseudodeficiency.
- Existing assays may lack sensitivity for detecting low ARSA levels.
Purpose of the Study:
- To develop a simple and accurate assay for determining low residual arylsulfatase A activity.
- To differentiate between MLD patients and pseudodeficiency individuals using residual ARSA activity.
- To quantify ARSA activity in cultured skin fibroblasts from MLD patients and controls.
Main Methods:
- Utilized the differential activity of arylsulfatase A and B at 0°C and 37°C.
- Employed 4-nitrocatechol-sulfate as a chromogenic substrate.
- Assayed residual ARSA activity in cultured skin fibroblasts.
Main Results:
- Arylsulfatase A activity was 24% at 0°C compared to 37°C, while arylsulfatase B was nearly inactive at 0°C.
- Residual ARSA activities in late-infantile MLD patients were 0.0%, juvenile patients 1.0%, and adult patients 4.4-14%.
- Healthy pseudodeficient individuals showed residual ARSA activity between 18% and 32%.
Conclusions:
- The developed assay accurately quantifies low residual arylsulfatase A activity.
- This assay effectively distinguishes MLD patients from pseudodeficiency individuals.
- The findings support the use of this assay for diagnosing MLD subtypes.